SFRP4 gene expression is increased in aggressive prostate cancer

scientific article published on 27 October 2017

SFRP4 gene expression is increased in aggressive prostate cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1092371233
P356DOI10.1038/S41598-017-14622-3
P932PMC publication ID5660209
P698PubMed publication ID29079735

P50authorTone F. BathenQ61104171
May-Britt TessemQ64706553
Finn DrabløsQ43415197
P2093author name stringAnna M Bofin
Elise Sandsmark
Helena Bertilsson
Maria K Andersen
Morten B Rye
P2860cites workLong-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence.Q51050747
A new method to provide a fresh frozen prostate slice suitable for gene expression study and MR spectroscopyQ57185246
Conducting Meta-Analyses in R with the metafor PackageQ58423162
Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancerQ73937761
Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancerQ83698264
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomyQ87828465
Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signalingQ22011203
Hallmarks of Cancer: The Next GenerationQ22252312
Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitroQ24307058
Overdiagnosis and overtreatment of prostate cancerQ26859596
Global cancer statistics, 2012Q27860501
Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's DiseaseQ28115466
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancerQ28251800
An accurate prostate cancer prognosticator using a seven-gene signature plus Gleason score and taking cell type heterogeneity into accountQ28484126
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomyQ28534277
Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genomeQ29616165
Integrative genomic profiling of human prostate cancerQ29619905
Molecular sampling of prostate cancer: a dilemma for predicting disease progressionQ33541296
In silico estimates of tissue components in surgical samples based on expression profiling dataQ33642598
Metastatic patterns of prostate cancer: an autopsy study of 1,589 patientsQ33904020
WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancerQ34266112
Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancerQ34625191
The Molecular Taxonomy of Primary Prostate CancerQ34674332
Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressivenessQ34693066
Diagnosis of prostate cancer using differentially expressed genes in stromaQ34763431
Secreted Frizzled-related proteins: searching for relationships and patternsQ34811402
Molecular differences in transition zone and peripheral zone prostate tumorsQ36067907
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort studyQ36106271
sFRP4-dependent Wnt signal modulation is critical for bone remodeling during postnatal development and age-related bone lossQ36841079
Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and diseaseQ37102953
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancerQ37520447
A novel non-canonical Wnt signature for prostate cancer aggressivenessQ37706021
Secreted frizzled-related protein 4 and its implications in cancer and apoptosis.Q38287048
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading SystemQ38613858
SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanisms.Q38749465
The Landscape of Prognostic Outlier Genes in High-Risk Prostate CancerQ38814732
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancerQ39292672
Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomyQ40369700
Gene expression analysis of prostate cancersQ40664417
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.Q46658469
Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopyQ46843127
Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samplesQ47892665
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomyQ50260314
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)14276
P577publication date2017-10-27
P1433published inScientific ReportsQ2261792
P1476titleSFRP4 gene expression is increased in aggressive prostate cancer
P478volume7

Reverse relations

cites work (P2860)
Q92382465High expression of fibronectin 1 indicates poor prognosis in gastric cancer
Q56989931Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates
Q64242272SFRP4 is a prognostic marker and correlated with Treg cell infiltration in pancreatic ductal adenocarcinoma

Search more.